Alliance Member-Only Meeting with Peter Marks, FDA’s CBER

If your organization is a Research!America alliance member, email Jacqueline Lagoy at Jlagoy@researchamerica.org for a link to our members-only alliance discussion with Peter Marks, MD, PhD, director of the Center for Biologics Evaluation and Research (CBER) at FDA. We’ve asked Dr. Marks to discuss efforts to shape a robust, cost- and time-efficient regulatory review pathway for advances in gene therapy.  Offering unimagined hope for the treatment and cure of rare childhood diseases and other treatment-elusive health threats, gene therapy is one of the most promising, and challenging, areas of focus for 21^st century science.  Join us with your questions and insights!